DS-2243a

· Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DS-2243a, covering 2025-07-24 to 2025-07-24. Get the full timeline:

Most recent: Clinical Trial Update: First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors [Phase 1]